Our first week of the second quarter wasn’t very good. And because we are dashing north to try our luck with clear skys in New England for the eclipse, the commentary for this week will be restricted, especially for the gyrations of the individual issues. It was a bad week for the biotech indices, with the NASDAQ biotech composite slipping into the red YTD after a -3.5% hit this week and the S&P biotechs had an even worse -5.1% drop, but still managing YTD performance of $1.06k.
I will remind everyone that the TCON’s drop-off -99.7% during the week, while clearly bad, was not catastrophic. That’s because it was a loss of 100% of its original price not its current price. It had been doing pretty well previously, in fact holding the #5 spot in the YTD performance last week (+145%), so now this week’s big loss put it at a respectable, rather than spectacular return of +45%
I note that ALONER achieved his first place performance for the past week +$10.3k without owning any of the high flying stocks.
BLADERUNNER is still running ahead of BULBAMAN. BLADERUNNER's second place performance for the week opened up the gap between them to $38k. BLADERUNNER owed their weekly result to including both CRDF and CRIS in their portfolio.
Report Time Ranges
|
|
|
|
|
| From
| To
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Recent
| 3/29/24
| 4/5/24
|
|
|
|
|
|
|
|
| YTD
| 12/31/2023
|
|
|
|
| Index Portfolios’ Performance
|
|
|
|
| Symbol
| Recent P/L
| Recent %
| YTD P/L
|
|
|
|
|
|
|
|
| ^IXIC
| -$872.26
| -0.8%
| $8,241.55
|
|
|
|
|
|
|
|
| ^NBI
| -$3,499.10
| -3.5%
| -$2,140.45
|
|
|
|
|
|
|
|
| ^SPSIBI
| -$5,381.16
| -5.1%
| $1,058.14
|
|
|
|
| Share Performance
| Recent Performance
| YTD Performance
|
| Top Five
|
| Bottom Five
|
| Top Five
|
| Bottom 5
| Symbol
| P/L / Initial Price
| Symbol
| P/L / Initial Price
| Symbol
| YTD P/L / Initial Price
| Symbol
| YTD P/L/ Initial Price
| PYXS
| 66.7%
| TCON
| -99.7%
| VINC
| 370.3%
| AMLX
| -82.2%
| CRIS
| 46.5%
| GRTS
| -78.4%
| VKTX
| 310.8%
| CNSP
| -79.6%
| VINC
| 41.5%
| APGE
| -34.5%
| CRDF
| 294.6%
| PACB
| -65.9%
| PMN
| 38.3%
| VERV
| -34.1%
| JSPR
| 273.9%
| NERV
| -58.7%
| CRDF
| 33.8%
| VKTX
| -29.8%
| PYXS
| 203.3%
| EYEN
| -57.2%
| Average and Median Portfolio Performance
|
| Recent P/L
|
|
|
| YTD P/L
|
|
|
| Avg.
| Median
|
|
|
| Avg
| Median
|
|
|
| -$3,952.41
| -$3,483.17
| JACK HARTMANN
|
| $21,273.92
| $8,518.66
| JACK HARTMANN
| Top Seven Portfolio Performances
| Top Recent Performers
| Top YTD Performers
| Contestant (Prev. Rank)
| Recent P/L
| P/L vs. ^SPSIBI
| YTD P/L (Rank)
| Contestant (Prev. Rank)
| YTD P/L
| vs. Top Portfolio
| P/L vs. ^SPSIBI
| Rec. P/L (Rank)
| 1 - ALONER (5)
| $10,296.60
| $15,677.75
| $7,210.30 (10)
| 1 - BLADERUNNER (1)
| $110,265.71
| ——
| $109,207.57
| $9,813.32 (2)
| 2 - BLADERUNNER (16)
| $9,813.32
| $15,194.47
| $110,265.71 (1)
| 2 - BULBAMAN (2)
| $72,334.03
| $37,931.68
| $71,275.88
| -$14,311.54 (16)
| 3 - TRACE I11 (7)
| $6,574.41
| $11,955.57
| $36,583.53 (5)
| 3 - RAJU_BIJLEE (3)
| $45,988.23
| $64,277.48
| $44,930.08
| -$11,180.78 (15)
| 4 - DART LANZER (15)
| -$2,084.15
| $3,297.00
| -$2,184.49 (14)
| 4 - ERIKOTTO (4)
| $42,414.86
| $67,850.84
| $41,356.72
| -$2,458.50 (6)
| 5 - A. J. MULLEN (13)
| -$2,362.80
| $3,018.35
| -$22,100.19 (17)
| 5 - TRACE I11 (8)
| $36,583.53
| $73,682.18
| $35,525.39
| $6,574.41 (3)
| 6 - ERIKOTTO (11)
| -$2,458.50
| $2,922.66
| $42,414.86 (4)
| 6 - TOMATO (5)
| $26,141.20
| $84,124.50
| $25,083.06
| -$17,736.71 (17)
| 7 - ARTHUR RADLEY (17)
| -$2,678.70
| $2,702.45
| -$5,572.49 (15)
| 7 - TECHNETIUM (7)
| $22,050.87
| $88,214.84
| $20,992.73
| -$8,305.30 (13)
| 8 - KATHLEEN (9)
| -$2,855.06
| $2,526.10
| $741.96 (13)
| 8 - DEW_DILIGENCE (6)
| $21,892.15
| $88,373.56
| $20,834.01
| -$8,474.44 (14)
| Top Portfolios’ Contents
| Top Recent Performance Portfolio (ALONER)
| Top YTD Performance Portfolio (BLADERUNNER)
| Symbol (Rank)
| Initial Allocation
| Value/Total | ROI
| YTD Stock P/L
| Recent Stock P/L
| % Current Price Change for $1,000 P/L
| Symbol (Rank)
| Initial Allocation
| Value/Total | ROI
| YTD Stock P/L
| Recent Stock P/L
| % Current Price Change for $1,000 P/L
| ACRS
| 5.00%
| 5.3% | 13.3%
| $666.67
| -$238.10
| 17.6%
| BCAB
| 10.00%
| 7.3% | 54.5%
| $5,447.15
| $1,463.41
| 6.5%
| AFMD
| 20.00%
| 19.3% | 3.7%
| $736.00
| $3,776.00
| 4.8%
| CRDF
| 20.00%
| 37.5% | 294.6%
| $58,918.92
| $6,756.76
| 1.3%
| CDTX
| 20.00%
| 27.3% | 46.1%
| $9,219.14
| $6,045.34
| 3.4%
| CRIS
| 10.00%
| 6.3% | 31.8%
| $3,176.47
| $4,650.98
| 7.6%
| CLSD
| 5.00%
| 5.2% | 11.1%
| $555.56
| -$982.91
| 18.0%
| GLYC
| 10.00%
| 5.5% | 16.5%
| $1,652.54
| -$1,059.32
| 8.6%
| CRVS
| 20.00%
| 18.5% | -0.6%
| -$113.64
| -$340.91
| 5.0%
| IMMP
| 10.00%
| 5.5% | 16.7%
| $1,666.67
| $1,958.33
| 8.6%
| KZIA
| 20.00%
| 15.4% | -17.2%
| -$3,449.37
| $2,452.79
| 6.0%
| IOVA
| 20.00%
| 15.8% | 66.4%
| $13,284.13
| -$3,173.43
| 3.0%
| MRNA
| 5.00%
| 4.8% | 3.4%
| $172.45
| -$185.02
| 19.3%
| JSPR
| 10.00%
| 17.8% | 273.9%
| $27,389.10
| $177.44
| 2.7%
| TWST
| 5.00%
| 4.1% | -11.5%
| -$576.51
| -$230.60
| 22.6%
| REPL
| 10.00%
| 4.2% | -12.7%
| -$1,269.28
| -$960.85
| 11.5%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
